ELVN
Enliven Therapeutics, Inc. Common StockstockNASDAQ
At CloseNov 18, 2026 3:59:52 PM EST
44.91USD-4.141%(-1.94)747,613
After-hoursNov 18, 2026 4:00:30 PM EST
44.89USD-0.045%(-0.02)
ELVN Financials
In Q3 FY 2026 (ended ), Enliven Therapeutics, Inc. Common Stock (ELVN) reported net income of −$27.7M, operating cash flow of −$12.56M, and assets of $897.23M (filed ).
Loading financial statements…